Viveve Medical EBIT

Viveve Medical (VIVE) currently reports a EBIT of $-21M as of September 2022. That compares with $-20M in the prior-year period — down 5.0% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Viveve Medical's EBIT history and peer comparisons.

Viveve Medical's EBIT decreased from $-20M to $-21M — a 5.0% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Viveve Medical's EBIT of $-21M is lower than the Healthcare sector average of $23B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Viveve Medical reported $-21M in EBIT as of September 2022. That compares with $-20M in the prior-year period — down 5.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-21M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Viveve Medical, and consider following VIVE for alerts when major investors trade the stock.